病患與療程條件
列印摘要
病患參數
- AMH: --
- 體重: 60.0 kg
- 使用情境: 初次使用
- 前次取卵反應: 不適用
- 使用天數: 7 天
計算結果
- 每日建議劑量: -- μg
- Follitropin-α 等效劑量: -- IU
- 總共需要劑量: -- μg
- 36 μg 筆數估算: -- 支
References
- European Medicines Agency. (2023, October 4). Rekovelle product information and EPAR. EMA.
- Qiao, J., et al. (2021). A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients. Human Reproduction, 36(9), 2452-2462.
- Bosch, E., et al. (2019). Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial. Reproductive BioMedicine Online, 38(2), 195-205.
- electronic medicines compendium. (2025, July 14). Rekovelle 12/36/72 micrograms summary of product characteristics.